Search results for "gastric"

showing 10 items of 536 documents

Rare Candida albicans overgrowth in an immunosuppressed patient: case report of a malignant tumor-like gastric lesion.

2011

Candida albicantumor-like gastric lesion
researchProduct

Degenerative and regenerative processes involved in midgut pseudotumor formation in the stick insect (Carausius morosus)

2009

Spontaneous and experimentally induced pseudotumor formation in Carausius morosus impairs the midgut tissue homeostasis. Spontaneous pseudotumor formation begins by the break down of a single or a small group of columnar cells (CCs) and is followed by the degeneration of neighboring CCs. There are not only marked similarities but also decisive differences between normal dying CCs in healthy specimens and the degeneration of CCs leading to pseudotumors: in both cases, the apical cell parts with the nucleus are extruded into the midgut lumen, but only during of pseudotumor formation an "amorphous substance" originates from the basal parts of the CCs. Hemocytes are attracted to this substance …

Carausius morosusPathologymedicine.medical_specialtyHemocytesInsectaCellular differentiationColumnar CellGranuloma Plasma CellDigestive System Physiological PhenomenaStomatogastric nervous systemmedicineAnimalsHomeostasisRegenerationProgenitor cellTissue homeostasisCell ProliferationbiologyStem CellsfungiCell DifferentiationMidgutbiology.organism_classificationstomatognathic diseasesAnimal Science and ZoologyStem cellDigestive SystemDevelopmental BiologyJournal of Morphology
researchProduct

Midgut pseudotumors and the maintenance of tissue homeostasis: studies on aging and manipulated stick insects.

2009

Stick insects (Carausius morosus) develop pseudotumors in aging adults. Pseudotumor formation starts at the M2 midgut region where an accumulation of stomatogastric nerve terminals is observed. Pseudotumors arise from dying columnar cells whose basal parts form an “amorphous substance” at the basement membrane whereas the apical parts, including the nucleus, are expelled into the gut lumen. The “amorphous substance” is ensheathed by hemocytes. These nodules, which do not melanize, characterize the phenotype of the pseudotumors. With age, cell death and pseudotumor infestation increases. It is shown that the maintenance of midgut tissue homoeostasis is disturbed and becomes more serious with…

Carausius morosusProgrammed cell deathPathologymedicine.medical_specialtyAgingInsectaMidgutColumnar CellBiologybiology.organism_classificationModels BiologicalGastrointestinal Tractstomatognathic diseasesStomatogastric nervous systemmedicineAnimalsHomeostasisAnimal Science and ZoologyStem cellHomeostasisTissue homeostasisDevelopmental BiologyJournal of morphology
researchProduct

Endotoxin inhibition of distension-stimulated gastric acid secretion in rat: mediation by NO in the central nervous system

1995

1. The involvement of nitric oxide in the acute inhibitory effects of low doses of endotoxin, following intracerebroventricular (i.c.v.) or intravenous (i.v.) administration, on gastric acid secretion stimulated by distension or i.v. infusion of pentagastrin has been investigated in the continuously perfused stomach of the anaesthetized rat. 2. The i.c.v. administration of E. coli endotoxin (800 ng kg-1) abolished the acid secretory response induced by gastric distension (20 cm water intragastric pressure) within 30 min of administration. 3. By contrast, submaximal rates of acid secretion induced by i.v. infusion of pentagastrin (8 micrograms kg-1 h-1) were not inhibited by i.c.v. administr…

Central Nervous SystemMalemedicine.medical_specialtyArginineBiologyDistensionArginineNitric OxideNitric oxideGastric Acidchemistry.chemical_compoundInternal medicinemedicineAnimalsSecretionRats WistarPharmacologyStomachGastric distensionRatsEndotoxinsPentagastrinNG-Nitroarginine Methyl Estermedicine.anatomical_structureEndocrinologychemistryGastric acidFemalemedicine.symptomResearch Articlemedicine.drugBritish Journal of Pharmacology
researchProduct

Nitrergic modulation of gastrointestinal function during early endotoxemia.

2006

After bacterial infection, the host reacts by signalling to the central nervous system where a cascade of physiologic, neuroendocrine and behavioural processes is orchestrated, collectively termed the acute phase response. Endotoxemia following Gram-negative bacterial infection induces a wide array of effects, including fever, loss of appetite and changes in gastrointestinal function that attempt to eliminate the challenge and restore homeostasis. Systemic administration of low doses of endotoxin (5-40 microg/kg) to rats is associated with changes in gastrointestinal motor function, inhibition of gastric acid secretion and increase in the gastric mucosal resistance to damage. These changes …

Central Nervous Systemmedicine.medical_specialtyCentral nervous systemMyenteric PlexusNitric OxideNitric oxideGastric Acidchemistry.chemical_compoundInternal medicineNitrergic NeuronsDrug DiscoverymedicineAnimalsHumansPharmacologyGastrointestinal tractbiologyStomachVagus NerveEndotoxemiaRatsNitric oxide synthaseGastrointestinal Tractmedicine.anatomical_structureEndocrinologychemistryGastric MucosaRegional Blood Flowbiology.proteinGastric acidNitric Oxide SynthaseGastrointestinal functionGastrointestinal MotilityHomeostasisCurrent pharmaceutical design
researchProduct

Toward Biopredictive Dissolution for Enteric Coated Dosage Forms

2016

The aim of this work was to develop a phosphate buffer based dissolution method for enteric-coated formulations with improved biopredictivity for fasted conditions. Two commercially available enteric-coated aspirin products were used as model formulations (Aspirin Protect 300 mg, and Walgreens Aspirin 325 mg). The disintegration performance of these products in a physiological 8 mM pH 6.5 bicarbonate buffer (representing the conditions in the proximal small intestine) was used as a standard to optimize the employed phosphate buffer molarity. To account for the fact that a pH and buffer molarity gradient exists along the small intestine, the introduction of such a gradient was proposed for p…

Chemistry PharmaceuticalCmaxBiological AvailabilityPharmaceutical Science02 engineering and technologyBuffers030226 pharmacology & pharmacyDosage form03 medical and health sciencesFirst pass effect0302 clinical medicineIVIVCCoated Materials BiocompatibleIntestine SmallDrug DiscoverymedicineHumansSolubilityDissolutionDosage FormsChromatographyAspirinGastric emptyingChemistryHydrogen-Ion Concentration021001 nanoscience & nanotechnologyEnteric coatingBicarbonatesDrug LiberationKineticsGastric EmptyingSolubilityArea Under CurveMolecular Medicine0210 nano-technologymedicine.drugMolecular Pharmaceutics
researchProduct

MECHANISM OF INHIBITION OF GASTRIC ACID SECRETION BY HYPERTONIC SOLUTIONS

1978

ChemistryMechanism (biology)Gastric acidTonicitySecretionPharmacology
researchProduct

Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactof…

2018

Objective: To investigate whether exposure to inhibitors of gastric acidity, such as H2 blockers or proton pump inhibitors, can independently increase the risk of infections in very low birth weight (VLBW) preterm infants in the neonatal intensive care unit. Study design: This is a secondary analysis of prospectively collected data from a multicenter, randomized controlled trial of bovine lactoferrin (BLF) supplementation (with or without the probiotic Lactobacillus rhamnosus GG) vs placebo in prevention of late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) in preterm infants. Inhibitors of gastric acidity were used at the recommended dosages/schedules based on the clinical judgmen…

ColonizationProton Pump InhibitorNeonatal intensive care unitAdministration OralHistamine H2 AntagonistProbioticGastroenterologyPediatricsH2 blocker0302 clinical medicineRisk FactorsInfant Very Low Birth Weight030212 general & internal medicineCandidaVLBW neonateLacticaseibacillus rhamnosusGestational agePerinatology and Child HealthHistamine H2 AntagonistsItalyNecrotizing enterocolitismedicine.symptomInfectionInfant PrematureHumanmedicine.medical_specialtyBirth weightGastric AcidSepsis03 medical and health sciencesEnterocolitis NecrotizingIntensive Care Units NeonatalSepsis030225 pediatricsInternal medicinemedicineH2 blockersHumansDietary Supplementbusiness.industryRisk FactorProbioticsInfant NewbornProton Pump Inhibitorsmedicine.diseaseLow birth weightLactoferrinConcomitantDietary SupplementsPediatrics Perinatology and Child HealthVLBW neonatesCandida; Colonization; H2 blockers; Infection; Lactoferrin; VLBW neonates; Pediatrics Perinatology and Child HealthGastric acidLactobacillus rhamnosubusinessNew Zealand
researchProduct

The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, B…

2011

Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the ne…

Continuous infusionComputer assisted radiotherapyFolic acidFluorodeoxyglucose f 18Gimeracil plus oteracil potassium plus tegafurInfection controlIntensity modulated radiation therapyDocetaxelCancer stagingMetastatic gastric cancerRisk FactorsPrevalenceDrug fatalityOverall survivalNeoplasm MetastasisPriority journalddc:616Conference paperdigestive oral and skin physiologyFolinic acidHematologyPrognosisOxaliplatinNuclear magnetic resonance imagingBevacizumabSurvival RateOncologyCyanocobalaminPractice Guidelines as TopicDrug dose reductionFluorouracilEsophageal adenocarcinomaHumanPositron emission tomographymedicine.medical_specialtyNeutropeniaStomach cancerStomach neoplasmsMEDLINESide effectStomach adenocarcinomaPatient careIrinotecanHelicobacter infectionPrimary tumorEndoscopic echographyAdvanced cancerEndoscopic mucosal resectionComputer assisted tomographyStomach Neoplasms/*diagnosis/pathology/*therapymedicineHumansGenetic Predisposition to DiseaseGastrointestinal cancerPhase 3 clinical trial (topic)Intensive care medicineSurvival ratePlaceboCapecitabineEpirubicinCa 19-9 antigenStomach Neoplasms/diagnosis/pathology/therapyHelicobacter pyloribusiness.industryCancerTrastuzumabCardiovascular riskmedicine.diseaseCancer susceptibilitydigestive system diseasesSurgeryClinical trialMetastasis potentialExpert opinionMeta analysis (topic)Cancer adjuvant therapyCarcinoembryonic antigenLower esophagus sphincterCisplatinCaloric intakebusinessCancer incidenceRegional differencesAnnals of Oncology
researchProduct

Surgery for obesity.

2005

PURPOSE OF REVIEW Bariatric surgery today is the only effective therapy for morbid obesity. Commonly performed procedures include adjustable gastric banding and vertical banded gastroplasty, variations of the Roux-en-Y gastric bypass, biliopancreatic diversion or duodenal switch, and mixed procedures. This review discusses key issues in the surgical management of morbid obesity. RECENT FINDINGS The two most common bariatric procedures performed worldwide are laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass. Controversy exists regarding the best surgical procedure. Weight loss decreases according to the procedures performed in following decreasing order: bili…

Cultural Studiesmedicine.medical_specialtyGastroplastyCost effectivenessbusiness.industrymedicine.medical_treatmentCost-Benefit AnalysisGastric BypassBariatric SurgeryPerioperativemedicine.diseaseObesityDuodenal switchEducationSurgeryMorbid obesityQuality of lifeWeight lossmedicineHumansmedicine.symptombusinessBiliopancreatic DiversionCurrent opinion in gastroenterology
researchProduct